(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
|
|
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 속성
- 밀도
- 1.46±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 1.14±0.20(Predicted)
안전
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin C화학적 특성, 용도, 생산
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 준비 용품 및 원자재
원자재
준비 용품
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 공급 업체
글로벌( 19)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
BOC Sciences | +1-631-485-4226 |
inquiry@bocsci.com | United States | 19553 | 58 |
HANGZHOU CLAP TECHNOLOGY CO.,LTD | 86-571-88216897,88216896 13588875226 |
sales@hzclap.com | CHINA | 6313 | 58 |
Nanjing Doge Biomedical Technology Co., Ltd | +86-25-58227606 +86-15305155328 |
sales@dogechemical.com | China | 4128 | 58 |
Aladdin Scientific | +1-833-552-7181 |
sales@aladdinsci.com | United States | 52927 | 58 |
Daicel Chiral Technologies (China)CO.,LTD | 021-50460086-9 15921403865 |
han_yajun@dctc.daicel.com | China | 6854 | 65 |
Tianjin Derchemist Science & Technology Co., Ltd. | 22-58627059 13920586291 |
zdcomcon@126.com | China | 2918 | 50 |
Shanghai Chiral bio-compound co., Ltd. | 021-5068 3667/17749785980/1029026415; 17749785980 |
1029026415@qq.com | China | 2791 | 58 |
Greenherbs Science and Technology Development Co., Ltd. | 010-61136123 |
pub02@greenherbs.com.cn | China | 4049 | 58 |
Shanghai Anyinuo Biomedical Technology Co., Ltd. | 021-34625901 |
420970979@qq.com | China | 5751 | 58 |
Shanghai Jizhi Biochemical Technology Co. Ltd. | 400-400-400-9004166 18616739031 |
3007523370@qq.com | China | 52712 | 58 |
(11aS)- 5-oxide-3,7-di-9-anthracenyl-10,11,12,13-tetrahydro-5-hydroxy-Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 관련 검색:
(11aS)-3,7-Bis[3,5-bis(trifluoromethyl)phenyl]-10,11,12,13-tetrahydro-5-hydroxy-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin 5-oxide
(11aS)-3,7-Bis(triphenylsilyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
(11aS)-3,7-Bis(4-(trifluoromethyl)phenyl)-10,11,12,13-tetrahydro-5-hydroxy-5-oxide-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin
(11aS)-10,11,12,13-Tetrahydro-5-hydroxy-3,7-bis(4-nitrophenyl)-diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin-5-oxide